Go Pro
→ DOJ Admits It In Court—Your Cash Can Be Seized Without Warning (From Priority Gold) (Ad)tc pixel Free BIVIW Stock Alerts

BioVie (BIVIW) Competitors

BioVie logo
$0.30 +0.02 (+5.17%)
As of 01:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

BIVIW vs. ALVOW, APLMW, ARAV, BIAFW, and CDIOW

Should you buy BioVie stock or one of its competitors? BioVie's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does BioVie compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, Alvotech had 1 more articles in the media than BioVie. MarketBeat recorded 3 mentions for Alvotech and 2 mentions for BioVie. Alvotech's average media sentiment score of 1.87 beat BioVie's score of 0.63 indicating that Alvotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alvotech
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
BioVie
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Alvotech beats BioVie on 3 of the 3 factors compared between the two stocks.

How does BioVie compare to Apollomics?

Apollomics (NASDAQ:APLMW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

In the previous week, BioVie had 1 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.89 beat BioVie's score of 0.63 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
BioVie Positive

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

Apollomics beats BioVie on 2 of the 3 factors compared between the two stocks.

How does BioVie compare to Aravive?

Aravive (NASDAQ:ARAV) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
BioVieN/AN/AN/AN/AN/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, BioVie had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for BioVie and 0 mentions for Aravive. BioVie's average media sentiment score of 0.63 beat Aravive's score of 0.00 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
BioVie Positive

Summary

Aravive and BioVie tied by winning 2 of the 4 factors compared between the two stocks.

How does BioVie compare to bioAffinity Technologies?

BioVie (NASDAQ:BIVIW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
bioAffinity Technologies$5.85MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
bioAffinity Technologies N/A N/A N/A

In the previous week, BioVie had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 2 mentions for BioVie and 1 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 1.89 beat BioVie's score of 0.63 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
BioVie Positive
bioAffinity Technologies Very Positive

Summary

bioAffinity Technologies beats BioVie on 2 of the 3 factors compared between the two stocks.

How does BioVie compare to Cardio Diagnostics?

BioVie (NASDAQ:BIVIW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

In the previous week, BioVie had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.89 beat BioVie's score of 0.63 indicating that Cardio Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
BioVie Positive
Cardio Diagnostics Very Positive

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

Summary

Cardio Diagnostics beats BioVie on 2 of the 3 factors compared between the two stocks.

Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIVIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIVIW vs. The Competition

Export
MetricBioVieBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.86B$7.21B$14.99B
Dividend YieldN/A3.65%2.57%11.71%
P/E RatioN/A14.53273.6125.47
Price / SalesN/A1,419.88698.20113.08
Price / CashN/A108.9477.7151.48
Price / BookN/A15.2210.406.34
Net IncomeN/A-$22.78M$3.49B$358.32M
7 Day Performance-17.34%-0.50%-0.12%0.29%
1 Month Performance5.17%0.63%-0.03%-3.10%
1 Year PerformanceN/A39.38%19.22%6.52%

BioVie Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIVIW
BioVie
N/A$0.31
+5.2%		N/AN/A$0.00N/AN/AN/A
ALVOW
Alvotech
N/A$0.30
-6.3%		N/A-71.0%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.01
flat		N/A-35.8%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.70
+79.0%		N/A+34.4%$0.00$5.85MN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BIVIW) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners
America Relied on Its Biggest Rival for This Military Metal
Antimony strengthens ammunition, missiles, sensors, batteries and semiconductors, yet the US ceded most produc...
i2i Marketing Group, LLC | Sponsoredtc pixel
$40,000,000,000,000
The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...
American Alternative | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
The national debt just passed $39 trillion
The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...
US Gold Bureau | Sponsoredtc pixel
Is This the New Normal for Gold?
Barrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...
Wall Street Logic | Sponsoredtc pixel
You’ve never seen anything like this before
For centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...
Porter & Company | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
I’ve spent years searching for overlooked cryptos before the crowd catches on. Here are a few of our past reco...
Crypto 101 Media | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel